BIOMEMORY LAUNCHES DNA SHIELD, THE FIRST COMMERCIAL PRODUCT BUILT ON ITS MOLECULAR IT PLATFORM

DNA ShieldPositive

AI Analysis

Summary

Biomemory launched DNA Shield, its first commercial product for sovereign data protection, following the acquisition of Catalog's assets and appointment of Laurent Guengant as CEO. The company opened Early Access to the product positioning itself as an early leader in molecular IT.

Outcome Details

Commercial product launch and Early Access opening

Importance:4/10

Sentiment:

0.60

product launchcommercialmolecular ITdata protectionacquisitionleadership appointment

Related Companies

$MOLN $STX.L $TRAX

Read the original article

Published by PR Newswire Biotech on October 15, 2026 10:00 AM

Read Original